[go: up one dir, main page]

EA200200995A1 - Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих - Google Patents

Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих

Info

Publication number
EA200200995A1
EA200200995A1 EA200200995A EA200200995A EA200200995A1 EA 200200995 A1 EA200200995 A1 EA 200200995A1 EA 200200995 A EA200200995 A EA 200200995A EA 200200995 A EA200200995 A EA 200200995A EA 200200995 A1 EA200200995 A1 EA 200200995A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mammals
infections
bacterial
protosoic
prevention
Prior art date
Application number
EA200200995A
Other languages
English (en)
Inventor
Уэйн Алан Боттнер
Питер Коннор Кэннинг
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200200995A1 publication Critical patent/EA200200995A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Описаны способы лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих, предусматривающие введение разовой дозы антибиотической композиции, включающей смесь азалидных изомеров и фармацевтически приемлемый носитель. Описаны также способы повышения у млекопитающего толерантности к острому или хроническому поражению в месте инъекции, предусматривающие введение разовой дозы антибиотических композиций, включающих смесь азалидных изомеров и фармацевтически приемлемый носитель. Кроме того, описана комбинация, включающая антибиотическую композицию, содержащую смесь азалидных изомеров, фармацевтически приемлемый носитель и инструкции по введению разовой дозы.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200995A 2000-04-27 2001-03-26 Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих EA200200995A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27
PCT/IB2001/000519 WO2001081358A1 (en) 2000-04-27 2001-03-26 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Publications (1)

Publication Number Publication Date
EA200200995A1 true EA200200995A1 (ru) 2003-04-24

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200995A EA200200995A1 (ru) 2000-04-27 2001-03-26 Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих

Country Status (30)

Country Link
US (2) US20020019353A1 (ru)
EP (1) EP1276747A1 (ru)
JP (1) JP2004516233A (ru)
KR (1) KR20030031479A (ru)
CN (1) CN1227258C (ru)
AP (1) AP2002002652A0 (ru)
AR (1) AR028041A1 (ru)
AU (1) AU4269301A (ru)
BG (1) BG107168A (ru)
BR (1) BR0110382A (ru)
CA (1) CA2407448A1 (ru)
CZ (1) CZ20023409A3 (ru)
EA (1) EA200200995A1 (ru)
GT (1) GT200100063A (ru)
HU (1) HUP0300585A3 (ru)
IL (1) IL152421A0 (ru)
IS (1) IS6559A (ru)
MA (1) MA26896A1 (ru)
MX (1) MXPA02010586A (ru)
NO (1) NO20025134L (ru)
OA (1) OA12257A (ru)
PA (1) PA8515601A1 (ru)
PE (1) PE20011188A1 (ru)
PL (1) PL359861A1 (ru)
SK (1) SK14882002A3 (ru)
TN (1) TNSN01063A1 (ru)
UY (1) UY26678A1 (ru)
WO (1) WO2001081358A1 (ru)
YU (1) YU78702A (ru)
ZA (1) ZA200208603B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
US8314071B2 (en) 2007-12-21 2012-11-20 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
JP6441794B2 (ja) * 2012-06-27 2018-12-19 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． 抗コクシジウム活性を有する植物部分および抽出物
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
US20180168196A1 (en) 2016-12-15 2018-06-21 Nestec Sa Compositions and methods that modulate bacteria in a companion animal
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
AU2018225390B2 (en) * 2017-02-22 2021-07-22 ISR Immune System Regulation Holding AB (publ) Novel immune stimulating macrolides
CA3120148A1 (en) * 2018-11-19 2020-05-28 Zikani Therapeutics, Inc. C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
WO2023038852A1 (en) * 2021-09-07 2023-03-16 Zoetis Services Llc Immunomodulating azalides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (ru) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членные азалиды и их применение как антибиотиков

Also Published As

Publication number Publication date
YU78702A (sh) 2005-11-28
ZA200208603B (en) 2003-10-24
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
CN1429232A (zh) 2003-07-09
IS6559A (is) 2002-09-20
MA26896A1 (fr) 2004-12-20
BR0110382A (pt) 2003-06-24
AU4269301A (en) 2001-11-07
AP2002002652A0 (en) 2002-12-31
AR028041A1 (es) 2003-04-23
US20040235759A1 (en) 2004-11-25
SK14882002A3 (en) 2004-11-03
PA8515601A1 (es) 2002-07-30
HUP0300585A2 (hu) 2003-06-28
CN1227258C (zh) 2005-11-16
KR20030031479A (ko) 2003-04-21
NO20025134D0 (no) 2002-10-25
OA12257A (en) 2003-11-06
UY26678A1 (es) 2001-12-28
MXPA02010586A (es) 2003-03-10
PL359861A1 (en) 2004-09-06
HUP0300585A3 (en) 2003-09-29
EP1276747A1 (en) 2003-01-22
CZ20023409A3 (cs) 2004-01-14
US20020019353A1 (en) 2002-02-14
CA2407448A1 (en) 2001-11-01
BG107168A (bg) 2003-07-31
NO20025134L (no) 2002-12-19
JP2004516233A (ja) 2004-06-03
TNSN01063A1 (fr) 2005-11-10
PE20011188A1 (es) 2001-11-24
WO2001081358A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
EA200200995A1 (ru) Применение композиций азалидных антибиотиков для лечения или предупреждения бактериальных или протозойных инфекций у млекопитающих
EA200000594A1 (ru) Новые макролиды
RS114004A (en) Modified 2' and 3'-nucleoside produgs for treating flaviridae infections
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
EA199901014A1 (ru) C-4"-замещенные макролидные производные
DE69833377D1 (de) Pharmazeutische zusammensetzungen enthaltend lysostaphin allein oder in kombination mit einem antibiotikum zur behandlung von staphylokokkeninfektionen
BR9900856A (pt) Antibioticos macrolideos de 3,6-cetal e enol-éter
CO5200778A1 (es) Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de b enzimidazol, administrada para prevenir y tratar el cancer e inhibir la metastasis
BRPI0408407A (pt) composto, composição farmacêutica, método de tratamento ou prevenção de dor, uso de um composto, e, processo para produzir um composto
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
HK1176318A1 (en) Injection device
BR0012442A (pt) Medicamento com ação protetora contra substâncias oxidantes tóxicas e particularmente contra substâncias cardiotóxicas
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
EA200001029A1 (ru) Производные гигромицина
BRPI0406795A (pt) Composições antiprotozoários que compreendem diclazuril
UY27947A1 (es) Prófarmaco ihnibidor de beta-lactamasa
BR9807444A (pt) Produto antimicrobial
ATE310521T1 (de) Praziquantel zusammensetzungen zur behandlung von krankheiten verursacht durch kokzidien
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
EA200400394A1 (ru) Фармацевтическая композиция для лечения диабетической невропатии
MY125300A (en) Synergistic combination for treatment of viral-mediated diseases
EA200100444A1 (ru) Производные гигромицина а в качестве антибактериальных агентов